Optiver Holding
MIRM icon

Optiver Holding’s Mirum Pharmaceuticals MIRM Stock Holding History

Optiver Holding’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5K Sell
98
-20
-17% -$2.01K ﹤0.01% 1707
2026
Q1 		$10.9K Buy
118
+58
+97% +$5.46K ﹤0.01% 1204
2025
Q4 		$4.74K Sell
60
-180
-75% -$12.9K ﹤0.01% 1403
2025
Q3 		$17.6K Buy
+240
New +$15.3K ﹤0.01% 1016

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's MIRM Position: Q2 2026 in Review

Optiver Holding reduced its Mirum Pharmaceuticals (MIRM) stake by 17% in Q2 2026, selling an estimated $2.01K and leaving 98 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Optiver Holding first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. The position peaked at $17.6K in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Optiver Holding held 98 shares of Mirum Pharmaceuticals worth $11.5K as of Q2 2026.
  • Optiver Holding sold 20 Mirum Pharmaceuticals shares in Q2 2026, an estimated $2.01K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1707 holding.
  • Optiver Holding first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Mirum Pharmaceuticals position peaked at $17.6K in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.